-
2024CUDA Conference | Professor Qiang Wei: Early Initiation of Novel Hormonal Therapy Brings More Benefits to Patients
The “4th Annual Conference of the Urology Physicians Branch of the Chinese Medical Association (2024)” was successfully held in Beijing from April 13th to 14th. During the conference, Professor Qiang Wei from West China Hospital, Sichuan University, shared insights on “Standard Treatment of mHSPC in the Era of Novel Hormonal Therapy.” Subsequently, “Oncology Frontier -…
-
BISC 2024丨Professor Junyan Qu: Interpretation of Anthrax Diagnosis and Treatment Plan (2023 Edition)
Anthrax is a zoonotic infectious disease caused by Bacillus anthracis infection, which still occurs sporadically in some areas of China. Anthrax can manifest in various clinical forms, with pulmonary anthrax having a mortality rate of over 80% and requiring management as a Class A infectious disease. In order to further standardize the clinical diagnosis and…
-
Professor Ning Shen ‘s Team: Mechanisms of Resistance to Cefiderocol in Highly Virulent Klebsiella pneumoniae | ESCMID Global 2024
With the escalating issue of antimicrobial resistance globally, newly emerged resistant strains pose a serious threat to public health. At the 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024), a study by Professor Ning Shen ‘s team from Peking University Third Hospital (Abstract No.: E0451) focused on the resistance issues of…
-
Professor Hongfei Duan：Advances in Diagnosis and Treatment of Mycobacterium avium Complex (MAC) Pulmonary Disease
Non-tuberculous mycobacteria (NTM) refers to all mycobacteria other than Mycobacterium tuberculosis and Mycobacterium leprae. NTM most commonly affect the lungs, causing NTM pulmonary disease (NTM-PD), which can even lead to disseminated disease in immunocompromised individuals. In recent years, with changes in the environment, updates in detection technology, and increased awareness among physicians, the incidence of…
-
Professor Sizhou Feng: Expert Consensus on the Diagnosis of Infections in Hematology Patients Using mNGS and Its Clinical Application
Patients with hematological disorders are often immunocompromised due to their primary disease or treatment, making them susceptible to infections. These infections often present atypically and can be caused by a wide variety of pathogens. Traditional diagnostic methods have low positivity rates and are time-consuming. Pathogen diagnosis is crucial for optimizing anti-infection treatment and improving patient…
-
Expert Perspective | Professor Jinghang Xu: Fever with Hepatic Damage – Focus on Non-Hepatotropic Viral Hepatitis
Non-hepatotropic viruses are significant pathogens in viral hepatitis. With advancements in diagnostic techniques, cases of hepatitis caused by non-hepatotropic viral infections are increasingly recognized in clinical settings. These viruses can manifest solely as hepatitis or in conjunction with other organ disorders. While most infections cause only mild liver damage, viruses such as HHV-6, Coxsackievirus, and…
-
Professor Qingyuan Zhang: Treatment Strategies for HR+/HER2- Advanced Breast Cancer Patients After Progression on CDK4/6i+ET
While CDK4/6 inhibitors plus endocrine therapy (ET) have become the standard first-line treatment for HR+/HER2- advanced breast cancer patients, there is currently no standardized recommendation for treatment strategies after progression on CDK4/6 inhibitors plus ET. At the “2024 National Breast Cancer Conference,” “Oncology Frontier” had the privilege of inviting Professor Qingyuan Zhang from Harbin Medical…
-
Professor Shaohua Zhang: “CSCO BC Guidelines” Updated, Evidence-Based, Leading Chinese Clinical Practice
The “Chinese Society of Clinical Oncology (CSCO) Breast Cancer Diagnosis and Treatment Guidelines (2024 Edition)” (“CSCO BC Guidelines”) have been updated again, incorporating richer evidence-based medicine from early to late stages, introducing more new treatment strategies and options. It has influenced the field of breast cancer treatment in China significantly. “Oncology Frontier” interviewed Professor Shaohua…
Connecting Medical Expertise through Media